Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pralsetinib 400, Thyroid Cancer

Protocol-ID: 2141 V1.0 (Mini), PRAL400, Thyroid Ca

Indication(s)

  • Thyroid Cancer (RET fusion positive, anaplastic); ICD-10 C73
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 23.09.2022